Global Exporter & Bulk Supplier of Bortlieva 2 mg Injection

🌍 Introduction

Are you seeking a trusted, globally compliant exporter of Bortlieva 2 mg Injection? At Ernest Oncology (a division of Ernest Pharmaceutical Pvt. Ltd.), we specialize in the secure, efficient, and compliant distribution of critical oncology formulations. We supply Bortezomib 2 mg injections to hospitals, specialized oncology clinics, and pharmaceutical wholesalers across the USA, UK, Australia, and South Africa.

🔬 1. Product Overview: Bortlieva 2 mg Injection

Bortlieva 2 mg Injection contains Bortezomib, a frontline antineoplastic agent belonging to the class of drugs known as proteasome inhibitors.

• Composition: Bortezomib 2 mg (as a sterile lyophilized powder)

• Therapeutic Class: Proteasome Inhibitor / Antineoplastic Agent

• Formulation Type: Single-dose vial for reconstitution

• Administration: Intravenous (IV) or Subcutaneous (SC) injection

⚙️ 2. Mechanism of Action

Bortlieva functions by targeting the internal recycling system of cancer cells, leading to their destruction:

• Proteasome Inhibition: Bortezomib reversibly inhibits the 26S proteasome, a multi-enzyme complex that breaks down proteins within cells.

• Protein Overload: By blocking this complex, damaged and misfolded proteins accumulate within the cancer cell.

• Apoptosis Induction: This toxic buildup triggers a stress response that leads to programmed cell death (apoptosis), effectively stopping the spread of the malignancy.

🏥 3. Therapeutic Indications

Bortlieva 2 mg Injection is clinically indicated for:

• Multiple Myeloma: Used in patients with newly diagnosed multiple myeloma or those who have received at least one prior therapy.

• Mantle Cell Lymphoma (MCL): Indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy.

⚠️ 4. Administration & Safety Guidelines

• Route: Must be administered by a healthcare professional via Intravenous (IV) or Subcutaneous (SC) route.

• Strict Warning: This medication must NEVER be administered into the spinal fluid (intrathecally).

• Common Side Effects: Fatigue, nausea, diarrhea, and peripheral neuropathy (numbness or tingling in hands/feet).

• Monitoring: Regular blood counts (platelets and white blood cells) are required, as it may cause thrombocytopenia or neutropenia.

PRESCRIPTION MEDICINE IS YES